About

Adjuvant Capital is a life sciences investment firm focused on global health. The company makes $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Adjuvant Capital was founded in 2012 by Charlie Petty, Glenn Rockman, and Kabeer Aziz and is based in New York.

Position in the VCSift Database

  • 33,888 investors in VCSift focus on the fintech sector.
  • 10,621 investors are based in New York, New York, United States.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Stages
seed series-a

Contact Information

ch•••••@adjuvantcapital.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Adjuvant

Search Investors